Imidafenacin-d13
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Imidafenacin-d13 Product Information
Imidafenacin-d13 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-100160.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Imidafenacin-d13
CAT No.
CS-T-100160
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C20H8D13N3O
Molecular Weight
332.48
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Imidafenacin-d13 is supplied with detailed characterization data compliant with regulatory guideline. Imidafenacin-d13 can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
"Imidafenacin-d13 is deutirium labelled imidafenacin which is a novel therapeutic agent for overactive bladder with antimuscarinic activity, on mediator release from urothelium and detrusor overactivity induced by cerebral infarction."
Synonyms
Imidafenacin-d13
Application Notes
"Imidafenacin-d13 is deutirium labelled imidafenacin which is a novel therapeutic agent for overactive bladder with antimuscarinic activity, on mediator release from urothelium and detrusor overactivity induced by cerebral infarction."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.